| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.002 |